Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01331434 · ClinicalTrials.gov registry record · NA
Bioequivalency Study of Exemestane 25 mg Tablet Under Fed Conditions
A NA study of Breast Cancer, sponsored by Roxane Laboratories.
- Completed
- Registry status
- NA
- Development phase
- 47
- Enrollment target
- 1
- Study location
NCT01331434: Completed NA study of Breast Cancer, sponsored by Roxane Laboratories.
NCT01331434 is a NA study of Breast Cancer that has completed, run by Roxane Laboratories. The registered enrollment target is 47 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01331434, a NA study of Breast Cancer, has completed, sponsored by Roxane Laboratories.
- COMPLETED
- Registry status
- NA
- Development phase
- 47 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of this study was to prove the bioequivalence of Exemestane 25 mg tablet under fed conditions.
Conditions Studied
Interventions
- DRUG exemestane
Study Locations (1)
Missouri
- Bio-Kinetic Clinical Applications, Inc. - Springfield
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 47 participants |
| Start Date | 2004-10 |
| Est. Completion | 2004-10 |
| Phase | NA |
What the finished NCT01331434 record still lists
NCT01331434 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 47 participants, a relatively small participant target, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (98% lower).
The record links to 1 condition, with Breast Cancer appearing as the primary indexed condition, and to 1 intervention - of which exemestane is the first listed.
NCT01331434 reports a single indexed study location in Missouri.
Frequently Asked Questions
What is clinical trial NCT01331434 about?
NCT01331434 is a clinical study titled "Bioequivalency Study of Exemestane 25 mg Tablet Under Fed Conditions". The objective of this study was to prove the bioequivalence of Exemestane 25 mg tablet under fed conditions.
What is the current status of trial NCT01331434?
This trial is currently completed. It is a NA study. The enrollment target is 47 participants. The study started on 2004-10. Estimated completion is 2004-10.
What conditions does trial NCT01331434 study?
This clinical trial studies the following conditions: Breast Cancer.
What interventions are being tested in trial NCT01331434?
The interventions under investigation include: exemestane (DRUG).
Who is sponsoring clinical trial NCT01331434?
This trial is sponsored by Roxane Laboratories, which has 93 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01331434 being conducted?
This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01331434's enrollment target sits among peer trials
47 832nd of 1224 higher than 391 of 1,224 other Breast Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Breast Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA
RECRUITING · NA
-
Post-operative Radiotherapy Omission in Selected Patients With Early Breast Cancer Trial International VErsion (PROSPECTIVE)
RECRUITING · NA
-
Resistance and Aerobic Exercise for Prevention in Women With Dense Breasts (REP-D)
RECRUITING · NA
-
Partial Breast Re-irradiation Using Ultra Hypofractionation (PRESERVE)
RECRUITING · NA
-
A Randomized Controlled Trial (RCT) to Determine the Efficacy of a Multidisciplinary CBT Based Pain Management Program for the Treatment of Aromatase Inhibitor Associated Musculoskeletal Symptoms (AIMSS) in Breast Cancer Survivors
RECRUITING · NA
-
Precise Oncology Interventions in Nutrition and Training (OnPoint)
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03313011 · 47 participants
The Neurobiology of Two Distinct Types of Progressive Apraxia of Speech
- NCT03467516 · 47 participants · Phase 2
Adoptive Transfer of Tumor Infiltrating Lymphocytes for Metastatic Uveal Melanoma
- NCT03886662 · 47 participants · Phase 1
A Study of LB-100 in Patients With Low or Intermediate-1 Risk Myelodysplastic Syndromes (MDS)
- NCT04013802 · 47 participants · Phase 1
TETRAVI Multivirus CTL for Treatment of EBV, CMV, Adenovirus, and BK Infections Post Allogeneic SCT.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia